Ceribell director trust sells 16,714 shares

Ceribell, Inc. director Josef Parvizi, through the Josef Parvizi Trust, sold 16,714 shares of common stock in open-market transactions on February 19, 2026 under a Rule 10b5-1 trading plan adopted on August 18, 2025.

Rhea-AI Filing Summary

Ceribell, Inc. director Josef Parvizi, through the Josef Parvizi Trust, sold 16,714 shares of common stock in open-market transactions on February 19, 2026 under a Rule 10b5-1 trading plan adopted on August 18, 2025.

The weighted average sale price was $20.27 per share, with individual trades between $20.00 and $20.77. Following the sale, the Josef Parvizi Trust held 722,652 shares. Separate Innovation ACP Trust and ACP 2021 Trust holdings were 907,911 and 369,088 shares, respectively, where Parvizi is a co-trustee and may be deemed to share beneficial ownership but disclaims it except to the extent of his pecuniary interest.

Insider Trade Summary

Net Seller: 16,714 shares

Net Sell 3 txns

Insider Parvizi Josef

Role Director

Sold 16,714 shs ($339K)

Type	Security	Shares	Price	Value
Sale	Common Stock	16,714	$20.27	$339K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 722,652 shares (Indirect, By Josef Parvizi Trust); Common Stock — 907,911 shares (Indirect, By Innovation ACP Trust); Common Stock — 369,088 shares (Indirect, By ACP 2021 Trust)

Footnotes (6)

1. F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.
2. F2. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
3. F3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
5. F5. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
6. F6. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ceribell (CBLL) report for Josef Parvizi?

Ceribell reported that director Josef Parvizi’s trust sold 16,714 shares of common stock in open-market transactions. The trades occurred on February 19, 2026 under a pre-established Rule 10b5-1 trading plan adopted on August 18, 2025.

At what prices were the Ceribell (CBLL) shares sold in this Form 4?

The reported weighted average sale price was $20.27 per share. Individual trades were executed at prices ranging from $20.00 to $20.77, and the reporting person offered to provide detailed trade-by-trade pricing information upon request to relevant parties.

How many Ceribell (CBLL) shares does the Josef Parvizi Trust hold after the sale?

After selling 16,714 shares, the Josef Parvizi Trust held 722,652 shares of Ceribell common stock. Josef Parvizi is the sole trustee of this trust and may be deemed to have beneficial ownership of these securities, subject to his pecuniary interest disclaimer.

What is the role of Rule 10b5-1 in this Ceribell (CBLL) insider sale?

The transaction was executed under a Rule 10b5-1 trading plan adopted on August 18, 2025. Such plans allow insiders to prearrange trades according to set instructions, providing a structured framework for selling shares over time.

What other Ceribell (CBLL) share holdings are reported for trusts linked to Josef Parvizi?

The filing reports 907,911 shares held by the Innovation ACP Trust and 369,088 shares held by the ACP 2021 Trust. Josef Parvizi is a co-trustee of both trusts and may be deemed to share beneficial ownership, subject to his pecuniary interest disclaimer.

Does Josef Parvizi fully claim beneficial ownership of the Ceribell (CBLL) trust shares?

No. While he may be deemed to have or share beneficial ownership as trustee or co-trustee, he expressly disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in those holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 12:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parvizi Josef

(Last) (First) (Middle)

C/O CERIBELL, INC.

360 N. PASTORIA AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		S(1)		16,714	D	$20.27(4)	722,652	I	By Josef Parvizi Trust(2)(3)
Common Stock								907,911	I	By Innovation ACP Trust(3)(5)
Common Stock								369,088	I	By ACP 2021 Trust(3)(6)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.

2. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.

3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

5. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.

6. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.

	/s/ Louisa Daniels, Attorney-in-Fact for Josef Parvizi	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.